Federica Gaudino

发表

Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor

S. Deaglio, F. Arruga, Samedy Ouk, 2017, Haematologica.

FOXA1 regulates alternative splicing in prostate cancer

M. Del Giudice, S. Guarrera, P. Rajan, 2022, Cell reports.

Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation

S. d'Auria, A. Varriale, S. Deaglio, 2019, Nature Communications.

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma

G. Madonna, P. Ascierto, M. Mandalà, 2018, Oncotarget.

A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus

C. Angeletti, E. Aronica, J. Wohlschlegel, 2020, The Journal of Biological Chemistry.

Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors.

S. Deaglio, N. Raffaelli, A. Managò, 2019, Antioxidants & redox signaling.

NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer

S. Deaglio, L. Sorci, N. Raffaelli, 2019, Front. Immunol..

NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma

S. Deaglio, F. Arruga, C. Riganti, 2020, Cancers.

Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT).

S. Deaglio, A. Managò, V. Audrito, 2020, Seminars in cell & developmental biology.

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p

F. Orso, D. Taverna, M. Mandalà, 2017, Oncotarget.